跳到主要內容

曾岱宗醫師

▍聯繫資訊
  • 辦公室:肝炎研究中心
  • 電話:院內分機 266613
  • Email:tctsenghbv@gmail.com
  • 實驗室網站:建置中

 

▍學歷
  • 國立台灣大學醫學院臨床醫學研究所博士
  • 國立台灣大學醫學院醫學系

 

曾岱宗醫師
▍經歷
  • 國立台灣大學醫學院附設醫院醫學研究部主治醫師
  • 國立台灣大學醫學院附設醫院內科部主治醫師
  • 國立台灣大學醫學院附設醫院金山分院主治醫師
  • 國家衛生研究院-博士後研究
  • 台北慈濟醫院主治醫師
  • 國立台灣大學醫學院附設醫院住院醫師

 

▍主要專長
  • 流行病學
  • 免疫學

 

▍研究方向
  • HBV epidemiology and immunology 
  • HCC immunology
  • Liver and tumor immune microenvironment

 

▍近五年論文發表
  • Yeo YH, Tseng TC, Hosaka T, Cunningham C, Fung JYY, Ho HJ, Kwak MS, Trinh HN, Ungtrakul T, Yu ML, Kobayashi M, Le AK, Henry L, Li J, Zhang J, Sriprayoon T, Jeong D, Tanwandee T, Gane E, Cheung RC, Wu CY, Lok AS, Lee HS, Suzuki F, Yuen MF, Kao JH, Yang HI, Nguyen MH. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. Clin Transl Gastroenterol. 2020 Sep;11(9):e00196. DOI: 10.14309/ctg.0000000000000196.
  • Tseng TC, Choi J, Nguyen MH, Peng CY, Siakavellas S, Papatheodoridis G, Wang CC, Lim YS, Lai HC, Trinh HN, Wong C, Wong C, Zhang J, Li JY, Kao JH. One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. HEPATOLOGY INTERNATIONAL. 2021 Feb;15(1):105-113. DOI: 10.1007/s12072-020-10124-z.
  • Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. JOURNAL OF HEPATOLOGY. 2020 Jun;72(6):1105-1111. DOI: 10.1016/j.jhep.2020.01.012.
  • Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, Yu ML, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, Chen DS, Kao JH. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. LIVER CANCER. 2020 Apr;9(2):207-220. DOI: 10.1159/000504650.
  • Tseng TC, Liu CJ, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Kuo Stephanie FT, Liu CH, Chen PJ, Chen DS, Kao JH. High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients with Chronic HBV Infection of Intermediate Viral Lord. GASTROENTEROLOGY. 157(6):1518-1529, 2019. 2019 Dec;157(6):1518-1529.e3. DOI: 10.1053/j.gastro.2019.08.028.
  • Liu YT*, Tseng TC*,Soong RS, et al. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment. Journal of Immunotherapy for Cancer. 2018 Dec 7;6(1):144. DOI: 10.1186/s40425-018-0462-3. (* Shared first authorship)
  • Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection. Alimentary Pharmacology & Therapeutics. 2018 Jun;47(11):1480-1489. DOI: 10.1111/apt.14619.
  • Tseng TC, Huang LR. Immunopathogenesis of Hepatitis B Virus. Journal of Infectious Diseases. 2017 Nov 16;216(suppl_8):S765-S770. DOI: 10.1093/infdis/jix356.
  • Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma. American Journal of Gastroenterology. 2017 Oct;112(10):1564-1574. DOI: 10.1038/ajg.2017.254.